CMP - Cipla Medpro South Africa Limited - Trading statement and clarification of
CMP
CMP
CMP - Cipla Medpro South Africa Limited - Trading statement and clarification of
results
CIPLA MEDPRO SOUTH AFRICA LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2002/018027/06)
(ISIN Number: ZAE000128179 Share Code: CMP)
("Cipla Medpro" or "the Company")
TRADING STATEMENT AND CLARIFICATION OF RESULTS
In terms of the JSE Limited Listings Requirements, companies are required to
publish a trading statement as soon as they are reasonably certain that the
financial results for the current reporting period will be more than 20%
different from those of the previous corresponding period.
Shareholders are advised that the Company expects earnings per share ("EPS") and
headline earnings per share ("HEPS") for the 12 months ended 31 December 2011 to
be between 77% and 85% higher than the EPS and HEPS for the prior corresponding
period.
As referred to in our previous trading update released on SENS on 11 August
2011, the statement of comprehensive income includes the settlement income from
Pfizer Ltd and Pfizer Laboratories (Pty) Ltd. In addition, due to IFRS
requirements, a significant unrealised gain relating to the mark to market of
forward exchange contracts has been accounted for in the EPS and HEPS. As a
result of these adjustments the increase in normalised EPS and HEPS will be less
than 20% when compared to the results for the 12 months ended 31 December 2010.
The information in this trading statement has not been reviewed or reported on
by Cipla Medpro`s auditors. The Company`s results for the 12 months ended 31
December 2011 are expected to be published on or about 15 March 2012.
23 February 2012
Durban
Investment Bank and Sponsor
Nedbank Capital
Date: 23/02/2012 16:30:26 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
